共 21 条
The CASP8-652 6N del promoter polymorphism and breast cancer risk:: a multicenter study
被引:47
作者:
Frank, Bernd
[1
,2
]
Rigas, Sushila H.
[3
]
Bermejo, Justo Lorenzo
[2
]
Wiestler, Miriam
[1
,2
]
Wagner, Kerstin
[2
]
Hemminki, Kari
[2
,4
]
Reed, Malcolm W.
[5
]
Sutter, Christian
[6
]
Wappenschmidt, Barbara
[7
]
Balasubramanian, Sabapathy P.
[5
]
Meindl, Alfons
Kiechle, Marion
Bugert, Peter
Schmutzler, Rita K.
[7
]
Bartram, Claus R.
[6
]
Justenhoven, Christina
Ko, Yon-Dschun
Bruening, Thomas
Brauch, Hiltrud
Hamann, Ute
Pharoah, Paul P. D.
Dunning, Alison M.
Pooley, Karen A.
Easton, Douglas F.
Cox, Angela
[3
]
Burwinkel, Barbara
[1
,2
]
机构:
[1] Helmholtz Univ Grp Mol Epidemiol, German Canc Res Ctr, DKFZ, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[3] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England
[4] Karolinska Inst, Ctr Family Med, Huddinge, Sweden
[5] Univ Sheffield, Sch Med, Acad Unit Surg Oncol, Sheffield, S Yorkshire, England
[6] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany
[7] Univ Cologne, Ctr Clin, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany
关键词:
deletion;
CASP8-652 6N del;
Sp1 binding site;
apoptosis;
breast cancer risk;
D O I:
10.1007/s10549-007-9752-z
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
A recent study on an Asian population reported a six-nucleotide insertion-deletion polymorphism (-652 6N del) in the CASP8 promoter region to be strongly associated with a decreased risk of multiple types of cancer, including breast cancer (BC). Here, we investigate the effect of this deletion in four independent large European BC case-control studies, including data from a total of 7,753 cases and 7,921 controls. The combined per allele odds ratio (OR) was 0.97 (95% confidence interval (CI), 95% CI = 0.93-1.02). The present result indicates that the CASP8 -652 6N del variant has no significant effect on BC risk in Europeans.
引用
收藏
页码:139 / 144
页数:6
相关论文